From the Guidelines
Pre-existing conditions that increase the risk for contrast-associated acute kidney injury (CA-AKI) include chronic kidney disease, diabetes mellitus, heart failure, advanced age, hypovolemia or dehydration, and hypotension. These conditions compromise kidney function or perfusion, making the kidneys more vulnerable to the nephrotoxic effects of contrast media. The risk factors for CA-AKI can be remembered using the following bullet points:
- Chronic kidney disease (especially with eGFR <30 mL/min/1.73m²) 1
- Diabetes mellitus 1
- Heart failure 1
- Advanced age (>75 years) 1
- Hypovolemia or dehydration 1
- Hypotension 1 Other significant risk factors include:
- Multiple myeloma 1
- Concurrent nephrotoxic medications (NSAIDs, aminoglycosides, certain antibiotics) 1
- Prior kidney injury 1 The combination of chronic kidney disease and diabetes poses a particularly high risk. The risk increases with higher contrast volumes and repeated contrast administration within a short timeframe. Patients with these risk factors should receive appropriate preventive measures such as:
- Adequate hydration with isotonic saline before and after contrast procedures 1
- Minimizing contrast volume 1
- Potentially temporary discontinuation of nephrotoxic medications when possible 1
From the Research
Pre-Existing Conditions as Risk Factors for Contrast-Associated Acute Kidney Injury
The following pre-existing conditions are considered risk factors for the development of contrast-associated acute kidney injury (CA-AKI):
- Cardiovascular disease 2, 3, 4
- Diabetes 2, 3, 4, 5, 6
- Hypertension 3, 4, 6
- Chronic kidney disease (CKD) 3, 4, 5
- Congestive heart failure 3, 4, 5
- Cerebrovascular disease 4
- Chronic liver disease 4
- Cancer 4
- Chronic obstructive pulmonary disease (COPD) 4
- Asthma 4
- HIV/AIDS 4
Mechanisms and Associations
These pre-existing conditions are associated with an increased risk of CA-AKI due to various mechanisms, including:
- Shared cardiovascular and metabolic risk factors 5
- Downstream effects on inflammation, oxidative stress, and neurohormonal pathways 5
- Defective placentation and angiogenesis in the case of pre-eclampsia 6
- Angiogenic imbalance and maternal susceptibility 6
Clinical Implications
Patients with these pre-existing conditions should be carefully evaluated and managed to prevent CA-AKI, including: